Bausch Health (STU:BVF) FFO


STU:BVF Bausch Health Companies Inc STU:BVF
52 GF Score
Price €4.25
GF Value €6.81
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Bausch Health FFO?

FFO (Funds from operations) only applies to REITs.

STU:BVF
52GF Score
Bausch Health Companies Inc STU:BVF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bausch Health (STU:BVF) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued. The current stock price of €4.25 is trading 37.6% below its estimated GF Value™ of €6.81. GuruFocus considers Bausch Health to be Possible Value Trap.

Key valuation signals for STU:BVF:

  • FFO:
  • GF Value™: €6.81 vs. price of €4.25 (37.6% below fair value)
  • GF Score™: 52/100 with 3 warning signs

No single metric tells the full story. See the STU:BVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bausch Health Business Description

Address 2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
52GF Score

Get the complete analysis for STU:BVF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.25
Price
€6.81
GF Value